The mechanisms of secondary antibody diversification processes

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Non-Hodgkin lymphoma

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Lisa Rimsza

Molecular Diagnosis and Prognosis in Aggressive Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Marc Brisson

Study and control of human papillomavirus related diseases (CANADA RESEARCH CHAIRHOLDER)

Hodgkin lymphoma Non-Hodgkin lymphoma

Smita Bhatia

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction

Hodgkin lymphoma

Pediatric oncology or childhood cancer Radiation Oncology